Grants and other funding activities
TDR funds specific research projects in diseases of poverty, which cover infectious diseases and the culture and environment that contribute to these problems. We also support the development of individuals and institutions in the countries where these diseases are prevalent.
Below are the current opportunities.
Calls for grant applications or/and letters of interest
Postgraduate training grants now available
Seven universities provide Masters and PhD level degrees that focus on implementation research. Applications need to be submitted to the universities.
Three requests for proposals to help develop new health R&D fund
Those interested are recommended to read all three proposals, since they are interrelated, but each request has specific focus and it is not required (nor expected) that one person/group would submit proposals for all three.
Intentions to bid will be accepted until 22 June 2015 at 23:59 CET
Full proposals will be accepted until 5 July 2015 at 23:59 CET
Bid Reference: TDR-R&D Fund-2015.01
Consultancy to Design a Financial Model for a Sustainable Health Product Research and Development Fund for Type III & II Diseases and the Specific R&D Needs of Developing Countries in Relation to Type I Diseases
Bid Reference: TDR-R&D Fund-2015.02
Consultancy to Prepare the TDR-based Scientifics Working Group for the Management of R&D Project Portfolios and a Sustainable Health Product Research and Development Fund for Type III & II Diseases and the Specific R&D Needs of Developing Countries in Relation to Type I Diseases
Bid Reference: TDR-R&D Fund-2015.03
Consultancy to Design a Compendium of Target Product Profiles for Type III & II Diseases and the Specific R&D Needs of Developing Countries in Relation to Type I Diseases
Joint call for proposals with EDCTP and the UK Medical Research Council:
Research and capacity development in support of the EVD response
Deadline for submission: 6 August 2015, 17:00 CET (extended)
The purpose of this Call for Proposals is to build and strengthen regional, national, institutional and individual capacities to conduct high quality health research (e.g. clinical trials, operational and/or implementation research) during infectious disease outbreaks resulting in health emergencies.